Proteasome inhibition in medaka brain induces the features of Parkinson’s disease

J. Neurochem. (2010) 115, 178–187.

[1]  Y. Sakaki,et al.  Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement , 2010, Neuroscience Research.

[2]  R. Takahashi,et al.  A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish , 2009, Neuroscience Research.

[3]  L. Petrucelli,et al.  A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. , 2009, Biochimica et biophysica acta.

[4]  F. Fujiyama,et al.  Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.

[5]  James Lowe,et al.  Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.

[6]  S. Sealfon,et al.  p53 Mediates Nontranscriptional Cell Death in Dopaminergic Cells in Response to Proteasome Inhibition* , 2006, Journal of Biological Chemistry.

[7]  P. Jenner,et al.  Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats , 2006, Annals of neurology.

[8]  J. Cooper,et al.  Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons , 2006, Annals of neurology.

[9]  J. Langston,et al.  Lack of nigrostriatal pathology in a rat model of proteasome inhibition , 2006, Annals of neurology.

[10]  J. Kordower,et al.  Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys , 2006, Annals of neurology.

[11]  Jeffrey H Kordower,et al.  Proteasome inhibition and Parkinson's disease modeling , 2006, Annals of neurology.

[12]  C. Olanow,et al.  Proteasome inhibitor–induced model of Parkinson's disease , 2006, Annals of neurology.

[13]  A. Lang,et al.  The proteasomal inhibition model of Parkinson's disease: “Boon or bust”? , 2006, Annals of neurology.

[14]  C. Olanow,et al.  Proteasomal dysfunction in sporadic Parkinson's disease , 2006, Neurology.

[15]  D. Perl,et al.  Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease , 2004, Annals of neurology.

[16]  B. Ghetti,et al.  Ubiquitination of α-Synuclein in Lewy Bodies Is a Pathological Event Not Associated with Impairment of Proteasome Function* , 2003, Journal of Biological Chemistry.

[17]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[18]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[19]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[20]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[21]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.